Finance

Lists
Why is HPHA up 6,19%?
Dive Deeper
HPHA:FRA
Heidelberg Pharma AG
€2,40
+6,19%
(+0,14) 1D
30 Sep., 08:01:15 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HPHA...
Open
€2,40
High
€2,40
Low
€2,40
Mkt. cap
114,15 m
Avg. vol.
488,00
Volume
0,00
52-wk high
€3,33
52-wk low
€2,31
EPS
-€0,71
No. of employees
41
Open
€2,40
High
€2,40
Low
€2,40
Mkt. cap
114,15 m
Avg. vol.
488,00
Volume
0,00
52-wk high
€3,33
52-wk low
€2,31
EPS
-€0,71
No. of employees
41
About Heidelberg Pharma AG
CEO-
Employees41
Founded1997
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Aug. 2025
Nov. 2025
Feb. 2026
Mei 2026
Revenue
47,13 k
21,44 k
3,03 m
4,34 m
Cost of goods sold
86,71 k
90,34 k
374,20 k
380,12 k
Cost of revenue
86,71 k
90,34 k
374,20 k
380,12 k
Research and development expenses
7,59 m
17,74 m
6,07 m
2,27 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,56 m
2,61 m
1,57 m
1,21 m
Operating expense
10,07 m
22,12 m
7,76 m
3,82 m
Total operating expenses
10,16 m
22,21 m
8,13 m
4,20 m
Operating income
-10,11 m
-22,19 m
-5,10 m
144,28 k
Other non operating income
1,41 m
-4,90 m
1,04 m
816,42 k
EBT including unusual items
-8,46 m
-20,18 m
-4,28 m
1,29 m
EBT excluding unusual items
-8,46 m
-20,31 m
-4,28 m
1,29 m
Income tax expense
-
1,05 m
-
425,14 k
Effective tax rate
-
-5,21%
-
33,01%
Other operating expenses
921,96 k
1,77 m
110,93 k
345,87 k
Net income
-8,46 m
-21,23 m
-4,28 m
862,76 k
Net profit margin
-17 956,70%
-99 007,38%
-141,02%
19,86%
Earnings per share
-
-
-
-
Interest and investment income
234,16 k
1,61 m
87,21 k
27,61 k
Interest expense
-1,14 k
-926,00
-711,00
-404,00
Net interest expenses
233,02 k
1,61 m
86,50 k
27,20 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-9,89 m
-22,13 m
-5,03 m
205,24 k
Gain or loss from assets sale
-92,00
4,07 k
14,90 k
-106,38 k
AI content may include mistakes. Learn more
Google-programme